FindTrial
Sign In

Effect Site Concentration of Remimazolam during general anesthesia by different age groups

Effect Site Concentration of Remimazolam during general anesthesia by different age groups in Patients Undergoing Target-controlled infusion for Minimally Invasive Surgery: a retrospective study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009171
Enrollment
90
Registered
2024-02-14
Start date
2024-01-22
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Yeouido St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who received targeted concentration-controlled infusion of remimazolam using the Schuttler model for elective surgery at Yeouido St. Mary's Hospital from September 2022 to July 31, 2023, patients who received

Exclusion criteria

Exclusion criteria: Patients administered other inhaled anesthetics or sedative hypnotics during anesthesia Patients whose dosage of remimazolam or remifentanil is unclear Patients with missing hemodynamic data

Design outcomes

Primary

MeasureTime frame
effect-site concentration of remimazolam at each sedation level—

Secondary

MeasureTime frame
bispectral index at each sedation level;Hemodynamic changes—

Countries

Korea, Republic of

Contacts

Public ContactKwon Hui Seo

The Catholic University of Korea, Yeouido St. Mary's Hospital

julianakh@hanmail.net+82-2-3779-1268

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026